Feng N - Search Results

1

A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance.

Yang L, Zhang Y, Tang Y, Wang Y, Jiang P, Liu F, Feng N. Yang L, et al. Among authors: feng n. Sci Rep. 2023 Apr 8;13(1):5779. doi: 10.1038/s41598-023-27975-9. Sci Rep. 2023. PMID: 37031216 Free PMC article.

2

Role of the functional MKK4 promoter variant (-1304T>G) in a decreased risk of prostate cancer: case-control study and meta-analysis.

Shao N, Wang Y, Lu K, Jiang WY, Li Q, Wang N, Feng NH, Hua LX. Shao N, et al. Among authors: feng nh. J Cancer Res Clin Oncol. 2012 Sep;138(9):1531-9. doi: 10.1007/s00432-012-1226-y. Epub 2012 Apr 24. J Cancer Res Clin Oncol. 2012. PMID: 22526163

3

Systematic review and meta-analysis of COX-2 expression and polymorphisms in prostate cancer.

Shao N, Feng N, Wang Y, Mi Y, Li T, Hua L. Shao N, et al. Among authors: feng n. Mol Biol Rep. 2012 Dec;39(12):10997-1004. doi: 10.1007/s11033-012-2001-5. Epub 2012 Oct 7. Mol Biol Rep. 2012. PMID: 23053989 Review.

4

Immunotherapy and endothelin receptor antagonists for treatment of castration-resistant prostate cancer.

Shao N, Wang Y, Jiang WY, Qiao D, Zhang SG, Wu Y, Zhang XX, Wang JL, Ding Y, Feng NH. Shao N, et al. Among authors: feng nh. Int J Cancer. 2013 Oct 1;133(7):1743-50. doi: 10.1002/ijc.28162. Epub 2013 Apr 8. Int J Cancer. 2013. PMID: 23504603

5

Role of the functional variant (-652T>G) in the XRCC4 promoter in prostate cancer.

Shao N, Li J, Xu B, Wang Y, Lu X, Feng N. Shao N, et al. Among authors: feng n. Mol Biol Rep. 2014 Nov;41(11):7463-70. doi: 10.1007/s11033-014-3636-1. Epub 2014 Aug 6. Mol Biol Rep. 2014. PMID: 25096509

6

OPN gene polymorphisms, rs17524488 GG/G, rs11730582 T/C, and rs9138 C/A, and cancer risk in a Chinese population.

Mi Y, Ren K, Dai F, Zhu L, Feng N. Mi Y, et al. Among authors: feng n. Sci Rep. 2015 Sep 15;5:14164. doi: 10.1038/srep14164. Sci Rep. 2015. PMID: 26369832 Free PMC article.

7

MiR-4638-5p inhibits castration resistance of prostate cancer through repressing Kidins220 expression and PI3K/AKT pathway activity.

Wang Y, Shao N, Mao X, Zhu M, Fan W, Shen Z, Xiao R, Wang C, Bao W, Xu X, Yang C, Dong J, Yu D, Wu Y, Zhu C, Wen L, Lu X, Lu YJ, Feng N. Wang Y, et al. Among authors: feng n. Oncotarget. 2016 Jul 26;7(30):47444-47464. doi: 10.18632/oncotarget.10165. Oncotarget. 2016. PMID: 27329728 Free PMC article.

8

Human HLA‑F adjacent transcript 10 promotes the formation of cancer initiating cells and cisplatin resistance in bladder cancer.

Li C, Wang Z, Feng N, Dong J, Deng X, Yue Y, Guo Y, Hou J. Li C, et al. Among authors: feng n. Mol Med Rep. 2018 Jul;18(1):308-314. doi: 10.3892/mmr.2018.9005. Epub 2018 May 9. Mol Med Rep. 2018. Retraction in: Mol Med Rep. 2024 Apr;29(4):63. doi: 10.3892/mmr.2024.13187 PMID: 29749526 Free PMC article. Retracted.

9

Lactobacillus reuteri A9 and Lactobacillus mucosae A13 isolated from Chinese superlongevity people modulate lipid metabolism in a hypercholesterolemia rat model.

Jiang J, Feng N, Zhang C, Liu F, Zhao J, Zhang H, Zhai Q, Chen W. Jiang J, et al. Among authors: feng n. FEMS Microbiol Lett. 2019 Dec 1;366(24):fnz254. doi: 10.1093/femsle/fnz254. FEMS Microbiol Lett. 2019. PMID: 31855230

10

Characteristics of the urinary microbiome in kidney stone patients with hypertension.

Liu F, Zhang N, Jiang P, Zhai Q, Li C, Yu D, Wu Y, Zhang Y, Lv L, Xu X, Feng N. Liu F, et al. Among authors: feng n. J Transl Med. 2020 Mar 17;18(1):130. doi: 10.1186/s12967-020-02282-3. J Transl Med. 2020. PMID: 32183836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,577 results

Search Page

Filters